ID   C3948
AC   CVCL_XY60
DR   cancercelllines; CVCL_XY60
DR   Wikidata; Q93439974
RX   PubMed=31368081;
CC   Doubling time: 30 hours (PubMed=31368081).
CC   Sequence variation: Mutation; HGNC; HGNC:28648; DIS3L2; Simple; p.Trp361Leu (c.1082G>T); Zygosity=Unspecified (PubMed=31368081).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Ser216Phe (c.647C>T); ClinVar=VCV000376708; Zygosity=Unspecified (PubMed=31368081).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu346Ter (c.1036G>T); ClinVar=VCV000634697; Zygosity=Hemizygous (PubMed=31368081).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=31368081
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 12
ST   D21S11: 31
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 26
ST   Penta D: 9
ST   Penta E: 13,14
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
RX   PubMed=31368081; DOI=10.1007/s12020-019-02009-5;
RA   Pinto A.T., Pojo M., Simoes-Pereira J., Roque R., Saramago A.,
RA   Roque L., Martins C., Andre S., Cabecadas J., Leite V., Cavaco B.M.;
RT   "Establishment and characterization of a new patient-derived
RT   anaplastic thyroid cancer cell line (C3948), obtained through
RT   fine-needle aspiration cytology.";
RL   Endocrine 66:288-300(2019).
//